Security key
74346M505
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN)
CUSIP: 74346M505
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 4,100,581
- Total 13F shares
- 264,549
- Share change
- +264,549
- Total reported value
- $1,798,689
- Price per share
- $6.82
- Number of holders
- 9
- Value change
- +$1,798,689
- Number of buys
- 9
Report period
Q4 2025
Institutions
9
Top holders
9
PMN full security history
Newer quarter: Q1 2026
ProMIS Neurosciences Inc. SEC filings
ProMIS Neurosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74346M505
Recent filing periods:
Top shareholders of PMN - ProMIS Neurosciences Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jeremy M. Sclar |
3/4/5
13D/G
|
10%+ Owner |
17%
from 13D/G
|
10,385,829
mixed-class rows
|
$5,072,406 | — | 25 Jul 2025 | |
| Shaf QIC LLC |
13D/G
3/4/5
|
10%+ Owner |
10%
|
10,534,639
|
$5,096,658 | $0 | 29 Jul 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
|
— |
10%
|
409,648
|
$2,790,563 | $0 | 31 Dec 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
295,187
|
$125,454 | — | 30 Sep 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
0.93%
from 13D/G
|
2,974,518
|
$1,264,170 | — | 30 Sep 2025 | |
| Slanix Paul Alex |
3/4/5
|
Director |
63%
|
6,058,738
|
$2,574,963 | — | 22 Oct 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
65%
|
6,233,497
|
$2,649,236 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
170,079
|
$72,284 | — | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.71%
|
68,057
|
$28,000 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.71%
|
67,687
|
$28,767 | — | 30 Sep 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.32%
|
30,366
|
$13,057 | — | 30 Sep 2025 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.3%
|
28,583
|
$12,148 | — | 30 Sep 2025 | |
| HOWARD FINANCIAL SERVICES, LTD. |
13F
|
Company |
0.27%
|
26,042
|
$11,068 | — | 30 Sep 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.27%
|
26,042
|
$11,068 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
18,428
|
$7,832 | — | 30 Sep 2025 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.13%
|
12,122
|
$5,153 | — | 30 Sep 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.12%
|
11,447
|
$5,000 | — | 30 Sep 2025 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
11,330
|
$5,000 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
9,000
|
$4,770 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
5,487
|
$2,000 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
2,506
|
$1,065 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$708 | — | 30 Sep 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
940
|
$422 | — | 30 Sep 2025 | |
| North Star Investment Management Corp. |
13F
|
Company |
0.01%
|
500
|
$212 | — | 30 Sep 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
254
|
$106 | — | 30 Sep 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
88
|
$37 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
68
|
$29 | — | 30 Sep 2025 | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,849,992
mixed-class rows
|
$2,337,589 | — | 25 Jul 2025 | |
| 19 Promis Title |
3/4/5
|
Other* |
—
mixed-class rows
|
4,010,077
mixed-class rows
|
$1,178,067 | — | 25 Jul 2025 | |
| Michael S. Gordon |
3/4/5
|
Other* |
—
mixed-class rows
|
4,010,077
mixed-class rows
|
$1,178,067 | — | 25 Jul 2025 | |
| Madge K. Shafmaster |
3/4/5
|
Director |
—
mixed-class rows
|
228,333
mixed-class rows
|
$270,916 | — | 12 Jun 2025 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| Larry Douglas Altstiel |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
165,000
|
— | — | 22 Sep 2025 | |
| Josh Mandel-Brehm |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| William W. Wyman |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q4 2025
As of 31 Dec 2025,
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
264,549 shares.
The largest 9 holders included
Ally Bridge Group (NY) LLC, SPHERA FUNDS MANAGEMENT LTD., UBS Group AG, Disciplined Equity Management, Inc., OSAIC HOLDINGS, INC., Federation des caisses Desjardins du Quebec, ROYAL BANK OF CANADA, TD Waterhouse Canada Inc., and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q4 2025 Across Filers
Q4 2025 holders
9
Q4 2025 holders
9
Holder diff
0
| Investor | Q4 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.